Consultant in Metabolic Medicine & Honorary Senior Clinical Lecturer
Shivani is a Consultant in Metabolic Medicine & Diabetes at Imperial College Healthcare NHS Trust and an Honorary Research Fellow within Imperial College London.
She is an NIHR Clinical Champion in Diabetes Stratified Medicine and has been awarded a Future Leaders Mentorship Awarded from the European Federation for the Study of Diabetes (2017).
She leads the MY DIABETES study, which recruits at over 40 sites around England and phenotypes young-onset diabetes in different ethnic groups. Her core research interest focuses on stratifying young-onset diabetes using biomarkers and genetics to improve treatment and identification of young-onset diabetes types.
Her other research interests include the detection of monogenic diabetes (MODY), ketosis-prone type 2 diabetes, the use and development of diabetes related biomarkers and laboratory testing guidelines.
Shivani was an NIHR Academic Clinical Fellow in metabolic medicine & chemical pathology and completed a PhD in the Section of Diabetes, Endocrinology & Metabolism, funded by a Sutherland-Earl Clinical Research Fellowship from the Diabetes Research and Wellness Foundation. She has trained in diabetes, clinical biochemistry and laboratory medicine and is a Fellow of the Royal College of Pathologists and Member of the Royal College of Physicians.
Shivani actively participants in undergraduate and postgraduate teaching programmes at Imperial College including supervision of BSc and MRes projects.
et al., 2021, Comparison of diabetic ketoacidosis in adults, during the SARS-CoV-2 outbreak and over the same time period for the 3 preceding years, Diabetes Care, Vol:44, ISSN:0149-5992, Pages:e29-e31
et al., 2021, Adverse outcomes in COVID-19 and diabetes – a retrospective cohort study from three London Teaching hospitals, Bmj Open Diabetes Research and Care, Vol:9, ISSN:2052-4897, Pages:1-10
et al., 2020, Covid-19 and diabetes: a complex bidirectional relationship, Frontiers in Endocrinology, Vol:11, ISSN:1664-2392
et al., 2020, Response to comment on Misra et al. homozygous hypomorphic HNF1A alleles are a novel cause of young-onset diabetes and result in sulfonylurea-sensitive diabetes. diabetes care 2020;43:909-912, Diabetes Care, Vol:43, ISSN:0149-5992, Pages:E155-E156
et al., 2020, Functional genomics in pancreatic β cells: recent advances in gene deletion and genome editing technologies for diabetes research., Front Endocrinol (lausanne), Vol:11, ISSN:1664-2392, Pages:1-20